Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.110
+0.070 (3.43%)
At close: Nov 21, 2024, 4:00 PM
2.102
-0.008 (-0.39%)
After-hours: Nov 21, 2024, 5:46 PM EST

Immuneering Statistics

Total Valuation

Immuneering has a market cap or net worth of $62.57 million. The enterprise value is $14.08 million.

Market Cap 62.57M
Enterprise Value 14.08M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date Nov 13, 2024
Ex-Dividend Date n/a

Share Statistics

Immuneering has 29.65 million shares outstanding. The number of shares has increased by 6.64% in one year.

Current Share Class 29.65M
Shares Outstanding 29.65M
Shares Change (YoY) +6.64%
Shares Change (QoQ) +0.64%
Owned by Insiders (%) 29.21%
Owned by Institutions (%) 14.78%
Float 20.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.10
P/TBV Ratio 1.19
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.99, with a Debt / Equity ratio of 0.07.

Current Ratio 7.99
Quick Ratio 7.32
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -71.81% and return on invested capital (ROIC) is -45.31%.

Return on Equity (ROE) -71.81%
Return on Assets (ROA) -42.35%
Return on Capital (ROIC) -45.31%
Revenue Per Employee n/a
Profits Per Employee -$853,950
Employee Count 68
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.19% in the last 52 weeks. The beta is -0.40, so Immuneering's price volatility has been lower than the market average.

Beta (5Y) -0.40
52-Week Price Change -62.19%
50-Day Moving Average 2.22
200-Day Moving Average 2.28
Relative Strength Index (RSI) 55.23
Average Volume (20 Days) 342,625

Short Selling Information

The latest short interest is 2.05 million, so 6.90% of the outstanding shares have been sold short.

Short Interest 2.05M
Short Previous Month 1.52M
Short % of Shares Out 6.90%
Short % of Float 9.74%
Short Ratio (days to cover) 1.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -61.82M
Pretax Income -56.07M
Net Income -58.07M
EBITDA -61.43M
EBIT -61.82M
Earnings Per Share (EPS) -$1.97
Full Income Statement

Balance Sheet

The company has $50.66 million in cash and $4.24 million in debt, giving a net cash position of $46.42 million or $1.57 per share.

Cash & Cash Equivalents 50.66M
Total Debt 4.24M
Net Cash 46.42M
Net Cash Per Share $1.57
Equity (Book Value) 57.72M
Book Value Per Share 1.86
Working Capital 48.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.26 million and capital expenditures -$246,437, giving a free cash flow of -$52.51 million.

Operating Cash Flow -52.26M
Capital Expenditures -246,437
Free Cash Flow -52.51M
FCF Per Share -$1.77
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Immuneering does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.64%
Shareholder Yield -6.64%
Earnings Yield -95.99%
FCF Yield -86.80%

Analyst Forecast

The average price target for Immuneering is $12.80, which is 506.64% higher than the current price. The consensus rating is "Buy".

Price Target $12.80
Price Target Difference 506.64%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -6.33%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1